Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma

« PreviousBlood Reviews
Volume 23, Issue 2 , Pages 87-93, March 2009

Antonio Palumbo
- Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy
- Corresponding author. Tel.: +39 0116336107; fax: +39 0116963737.
Meletios Dimopoulos
- Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
- Tel.: +30 210 3381541; fax: +30 210 3381511.
Jesus San Miguel
- Department of Hematology, University Hospital of Salamanca, Salamanca, Spain
- Tel.: +34 923291384.
Jean-Luc Harousseau
- Hôtel-Dieu Hospital, Nantes, France
- Tel.: +33 2 40 08 32 71; fax: +33 2 40 08 32 50.
Michel Attal
- Division of Hematology, Centre Hospitalier Université de Purpan, Toulouse, France
- Tel.: +33 (05) 61777784; fax: +33 (05) 61777541.
Mohamad Hussein
- H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
- Tel.: +1 813 745 8090; fax: +1 813 979 3071.
Stefan Knop
- Department of Hematology and Oncology, University Hospital, Würzburg, Germany
- Tel.: +49 931 201 0; fax: +49 931 201 70281.
Heinz Ludwig
- Wilhelminenspital, Vienna, Austria
- Tel.: +43 1491502101; fax: +43 1491501009.
Marie von Lilienfeld-Toal
- BMTU, Gledhow Wing, St. James’s University Hospital, Leeds Teaching Hospitals, Leeds, UK
- Tel.: +44 228 28715507; fax: +44 228 28714319.
Pieter Sonneveld
- Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
- Tel.: +31 10 463 3123; fax: +31 10 463 5814.